INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test

INOVIQ (ASX:IIQ) completed an analytical validation study for its blood test for ovarian cancer, identifying 85% of all samples tested, according to a Friday filing with the Australian Securities Exch

MT NewswiresApr 18 19:35 ET

A Look At The Fair Value Of INOVIQ Ltd (ASX:IIQ)

Yahoo FinanceMar 23 18:18 ET

Inoviq's Test Detects 19% More Breast Cancers Than Market Leader

Inoviq (ASX:IIQ) provided an update on its breast cancer study, saying the firm's SubB2M/CA15-3 test detected "over 80% of breast cancers across all stages with 93% specificity." The recently conclude

MT NewswiresFeb 23 06:22 ET

David Williams to Join INOVIQ Board

INOVIQ Limited (ASX: IIQ) has announced the appointment of David Williams as a Non-Executive Director and Chairman Elect, effective from the Annual General Meeting (AGM) scheduled for 29 November 2023

sharecafeOct 13, 2023 03:03 ET

Inoviq Appoints Chair Elect; Shares Climb 13%

Inoviq (ASX:IIQ) appointed David Williams as chair elect, effective from the Nov. 29 annual general meeting. Williams will succeed Geoffrey Cumming, who held the role since the acquisition of Sienna C

MT NewswiresOct 11, 2023 00:28 ET

Inoviq Signs Deal for Use of Biomarker Capture Product in the US

Inoviq (ASX:IIQ) signed a deal with contract diagnostic organization ResearchDx for the licensing and supply of its exosome biomarker capturing product EXO-NET in the US. The agreement will allow Rese

MT NewswiresSep 5, 2023 03:21 ET